HK FSDC Proposes Measures to Advance Biotech Hub Ambitions

The FSDC says allowing SPACs to list in Hong Kong will help to bolster the city's status as a fundraising hub for the healthcare and biotech sectors.

To continue reading...

Get access today

Sign up for a free 2-week trial and get instant, unrestricted and unlimited access to Regulation Asia.


Already taken your free trial? Get in touch with our team and enquire about a subscription today. Select subscribe below to view our subscription packages or you can email us at [email protected] to discuss your options.


To Top
Share via
Copy link
Powered by Social Snap